Heinz-Josef Lenz
University of Southern California
H-index: 122
North America-United States
Top articles of Heinz-Josef Lenz
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Analysis of immune-related genes (IRGs) and their potential role in sexual dimorphism in patients (pts) with metastatic colorectal cancer (mCRC). | Pooja Mittal Yan Yang Shivani Soni Francesca Battaglin Joshua Millstein | 2024/1/20 | |
Determinants of generalized self-efficacy and genetic knowledge among Hispanic/Latino colorectal cancer patients participating in ENLACE: A Cancer Moonshot Study | Cancer Research | Joel Sanchez Mendez Julie O Culver Charité N Ricker Natalia Gutierrez Sandra Algaze | 2024/3/22 |
Genome-wide association study (GWAS) and novel prognostic markers in metastatic colorectal cancer (mCRC). | Yan Yang Francesca Battaglin Shivani Soni Sandra Algaze Jae Ho Lo | 2024/1/20 | |
LMTK3 gene expression and the molecular landscape of colorectal cancer (CRC). | Lesly Torres-Gonzalez Francesca Battaglin Shivani Soni Yasmine Baca Joanne Xiu | 2024/1/20 | |
Plant-based diet and survival among patients with metastatic colorectal cancer: Findings from CALGB/SWOG 80405 (Alliance) | Cancer Research | En Cheng Fang-Shu Ou Chao Ma Alan P Venook Heinz-Josef Lenz | 2024/3/22 |
Evaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer | Breast Cancer Research and Treatment | Robert Hsu Batul Al-Zubeidy Daniel Flores Ari Nazarian Aaron Baugh | 2024/4/20 |
DNA mutational profiling in patients with colorectal cancer treated with standard of care reveals differences in outcome and racial distribution of mutations | Journal of Clinical Oncology | Federico Innocenti Wancen Mu Xueping Qu Fang-Shu Ou Omar Kabbarah | 2024/2/1 |
Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mendelian randomization study | Cell Reports Medicine | Hajime Yamazaki Samantha A Streicher Lang Wu Shunichi Fukuhara Róbert Wagner | 2024/2/20 |
Targeting circadian transcriptional programs in triple negative breast cancer through a cis-regulatory mechanism | bioRxiv | Yuanzhong Pan Tsu-Pei Chiu Lili Zhou Priscilla Chan Tia Tyresett Kuo | 2024 |
Multi-omics characterization of molecular features and global-local genomic ancestry analysis of colorectal cancer in Hispanic-Latinos | Science advances | Ziyu Li Xiangyu Gao Xinxin Peng Mei-Ju May Chen Zhe Li | 2020/2/26 |
Genomic analysis of oesophageal carcinoma (EC) to identify recurrent mutations in histone methyltransferases as a distinctive subset. | Jingyuan Wang Joanne Xiu Matthew James Oberley Francesca Battaglin Hiroyuki Arai | 2024/1/20 | |
A phase 1b/2 clinical study of onvansertib in combination with FOLFIRI/bevacizumab revealed a new role of PLK1 in regulating the hypoxia pathway in KRAS-mutant colorectal cancer | Cancer Research | Maya Ridinger Anju Karki Ramanand A Subramanian Errin Samuelsz Divora Yemane | 2024/3/22 |
Molecular and immune landscape by cyclin dependent kinase (CDK) 4/6 expression and TP53 mutational status in mismatch repair deficient/microsatellite instability-high (dMMR/MSI … | Alexandra Wong Nishant Gandhi Joanne Xiu Sandra Algaze Priya Jayachandran | 2024/1/20 | |
Abstract CT076: AFNT-211: A phase1 study of autologous CD4+ and CD8+ T cells engineered to express a high avidity HLA-A* 11: 01-restricted, KRAS G12V-specific, transgenic TCR … | Cancer Research | Shaunica Mitchell Binaish Khan Francis Payumo E Gabriela Chiorean Zhubin Gahvari | 2024/4/5 |
Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer | European Journal of Cancer | Hiroyuki Arai Yan Yang Yasmine Baca Joshua Millstein Tadamichi Denda | 2024/2/10 |
Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized … | Journal for ImmunoTherapy of Cancer | Heinz-Josef Lenz Aparna Parikh David R Spigel Allen L Cohn Takayuki Yoshino | 2024 |
Structure-based screening for potential ROR1 inhibitors and their potential as antitumor agents in pancreatic cancer cells | Cancer Research | Indrakant Kumar Singh Shradheya RR Gupta Pooja Mittal Shivani Soni Jae Ho Lo | 2024/3/22 |
Nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) as first-line (1L) treatment for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR … | Thierry Andre Elena Elez Eric Van Cutsem Lars Henrik Jensen Jaafar Bennouna | 2024/1/20 | |
A phase 1b study of the OxPhos inhibitor ME-344 in combination with bevacizumab in refractory metastatic colorectal cancer. | Patrick M Boland Heinz-Josef Lenz Mike Cusnir Vaia Florou Michael J Pishvaian | 2024/1/20 | |
Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma. | Karam Ashouri Yasmine Baca Joanne Xiu Shivani Soni Pooja Mittal | 2024/1/20 |
Co-Authors
